Garcia Yague, Angel Juan

Can Activation of NRF2 Be a Strategy against COVID-19?

  • Cuadrado A
  • Pajares M
  • Benito C
  • Jiménez-Villegas J
  • Escoll M
  • Fernández-Ginés R
  • Garcia Yagüe AJ
  • Lastra D
  • Manda G
  • Rojo AI
  • Dinkova-Kostova AT
... View more Collapse

Trends In Pharmacological Sciences (p. 598-610) - 1/9/2020

10.1016/ View at source

  • ISSN 01656147

Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.

  • Castro-Sánchez S, García-Yagüe ÁJ, López-Royo T, Casarejos M, Lanciego JL, Lastres-Becker I

Glia (p. 1752-1762) - 1/8/2018


  • ISSN 08941491
  • iMarina

CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies

  • Castro-Sánchez S, García-Yagüe ÁJ, Kügler S, Lastres-Becker I

Redox Biology (p. 101118-101118) - 1/4/2019


  • ISSN 22132317
  • iMarina

Nuclear import and export signals control the subcellular localization of nurr1 protein in response to oxidative stress

  • García-Yague A
  • Rada P
  • Rojo A
  • Lastres-Becker I
  • Cuadrado A

Journal Of Biological Chemistry (p. 5506-5517) - 22/2/2013

10.1074/jbc.m112.439190 View at source

  • ISSN 00219258

Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease

  • Lastres-Becker I, García-Yagüe AJ, Scannevin RH, Casarejos MJ, Kügler S, Rábano A, Cuadrado A

Antioxidants & Redox Signaling (p. 61-77) - 10/7/2016

10.1089/ars.2015.6549 View at source

  • ISSN 15230864

Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells

  • Galán-Ganga M, García-Yagüe ÁJ, Lastres-Becker I

Cellular And Molecular Neurobiology (p. 331-340) - 15/4/2019


  • ISSN 02724340
  • iMarina

The transcription factor nrf2 is a therapeutic target against brain inflammation

  • Innamorato N
  • Rojo A
  • García-Yagüe A
  • Yamamoto M
  • De Ceballos M
  • Cuadrado A

Journal Of Immunology (p. 680-689) - 1/1/2008

10.4049/jimmunol.181.1.680 View at source

  • ISSN 00221767

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

  • Pajares M, Jiménez-Moreno N, García-Yagüe ÁJ, Escoll M, de Ceballos ML, Van Leuven F, Rábano A, Yamamoto M, Rojo AI, Cuadrado A

Autophagy (p. 1902-1916) - 2/10/2016

10.1080/15548627.2016.1208889 View at source

  • ISSN 15548627

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

  • Herrera-Arozamena C
  • Estrada-Valencia M
  • Pérez C
  • Lagartera L
  • Morales-García JA
  • Pérez-Castillo A
  • Franco-Gonzalez JF
  • Michalska P
  • Duarte P
  • León R
  • López MG
  • Mills A
  • Gago F
  • García-Yagüe ÁJ
  • Fernández-Ginés R
  • Cuadrado A
  • Rodríguez-Franco MI
... View more Collapse

European Journal Of Medicinal Chemistry - 15/3/2020

10.1016/j.ejmech.2020.112090 View at source

  • ISSN 02235234

α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks

  • García-Yagüe ÁJ
  • Lastres-Becker I
  • Stefanis L
  • Vassilatis DK
  • Cuadrado A

Molecular Neurobiology (p. 6697-6711) - 1/1/2021

10.1007/s12035-021-02558-9 View at source

  • ISSN 08937648

This researcher has no books.

This researcher has no book chapters.

A0n alternative for reducing the layers in the construction of three-phase planar transformers

  • Prieto R
  • Asensi R
  • García O
  • Cobos J
  • Jerez F
  • Gerez F

Conference Proceedings - Ieee Applied Power Electronics Conference And Exposition - Apec (p. 1023-1026) - 30/4/2012

10.1109/apec.2012.6165944 View at source

  • ISSN 10482334

Regulation of the extracellular matrix glycoprotein Reelin by the transcription factor NRF2: A protective mechanism for the brain under oxidative stress

  • Garcia-Yague, Angel J
  • Cuadrado, Antonio

Free Radical Biology And Medicine - 1/1/2021

10.1016/j.freeradbiomed.2020.12.398 View at source

  • ISSN 08915849

This researcher has no working papers.

This researcher has no technical reports.

Desarrollo de fármacos activadores de NRF2 para terapias innovadoras de la enfermedad de alzheimer

  • Pajares Cabetas, Marta (Investigador/a)
  • GARCIA YAGUE, ANGEL JUAN (Investigador/a)
  • Robledinos Anton, Natalia (Investigador/a)
  • Rojo Sanchís, Ana Isabel (Investigador/a)
  • Garcia Lopez, Manuela (Investigador principal (IP))
  • MARTA PAJARES CABETAS (Miembro del equipo de investigación)
  • Angel Juan Garcia Yague (Miembro del equipo de investigación)
  • NATALIA ROBLEDINOS ANTON (Miembro del equipo de investigación)
  • MARIA ISABEL ESCOLL GUERRERO (Miembro del equipo de investigación)
  • ANA ISABEL ROJO SANCHIS (Miembro del equipo de investigación)
  • Cuadrado Pastor, Antonio (Investigador principal (IP))
... View more Collapse

Period: 01-01-2018 - 31-12-2021

Amount of funding: 95091,66 Euros.

  • iMarina

El factor de transcripción nrf2 en la patofisiología de la enfermedad de Alzheimer

  • Cuadrado Pastor, Antonio

Period: 01-06-2020 - 31-05-2023

Type of funding: National

Amount of funding: 369050,00 Euros.

  • iMarina

Regulación del factor de trascripción Nurr1 mediante cambios en su localización subcelular y su estabilidad por estrés oxidativo

  • Cuadrado Pastor, Antonio (Director) Doctorando: García Yagüe, Ángel


  • iMarina

This researcher has no patents or software licenses.

Last data update: 10/17/22 6:39 PM